REPORTS

Let’s Pullulate and Expand Your Business

Tuberculosis Vaccines Market - Global Professional Analysis and Forecast to 2026

Feb 11, 2020  |  190 PAGES  |  REPORT CODE: CMM266283
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Tuberculosis Vaccines market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.9% during the forecast period.

This report presents the market size and development trends by detailing the Tuberculosis Vaccines market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Tuberculosis Vaccines market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Tuberculosis Vaccines industry and will help you to build a panoramic view of the industrial development.

Tuberculosis Vaccines Market, By Type:

  • Immunotherapeutic Vaccines

  • Booster Vaccines

  • Others

Tuberculosis Vaccines Market, By Application:

  • Hospitals

  • Clinics

  • Others

Some of the leading players are as follows:

  • IDT Biologics

  • Taj Pharmaceuticals

  • GlaxoSmithKline

  • GreenSignal Bio Pharma

  • Sanofi

  • Serum Institute of India

  • China National Biotec Group

  • Bavarian Nordic

  • Japan BCG Lab

  • Merck

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Tuberculosis Vaccines Market: Technology Type Analysis

  • 4.1 Tuberculosis Vaccines Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Tuberculosis Vaccines Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 Immunotherapeutic Vaccines

    • 4.3.2 Booster Vaccines

    • 4.3.3 Others

5 Tuberculosis Vaccines Market: Product Analysis

  • 5.1 Tuberculosis Vaccines Product Market Share Analysis, 2018 & 2026

  • 5.2 Tuberculosis Vaccines Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Tuberculosis Vaccines Market: Application Analysis

  • 6.1 Tuberculosis Vaccines Application Market Share Analysis, 2018 & 2026

  • 6.2 Tuberculosis Vaccines Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Hospitals

    • 6.3.2 Clinics

    • 6.3.3 Others

7 Tuberculosis Vaccines Market: Regional Analysis

  • 7.1 Tuberculosis Vaccines Regional Market Share Analysis, 2018 & 2026

  • 7.2 Tuberculosis Vaccines Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 IDT Biologics

    • 9.1.1 IDT Biologics Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Taj Pharmaceuticals

    • 9.2.1 Taj Pharmaceuticals Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 GlaxoSmithKline

    • 9.3.1 GlaxoSmithKline Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 GreenSignal Bio Pharma

    • 9.4.1 GreenSignal Bio Pharma Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 Sanofi

    • 9.5.1 Sanofi Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 Serum Institute of India

    • 9.6.1 Serum Institute of India Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 China National Biotec Group

    • 9.7.1 China National Biotec Group Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 Bavarian Nordic

    • 9.8.1 Bavarian Nordic Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Japan BCG Lab

    • 9.9.1 Japan BCG Lab Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Merck

    • 9.10.1 Merck Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

 

The List of Tables and Figures (Totals 64 Figures and 157 Tables)

  • Figure Immunotherapeutic Vaccines Tuberculosis Vaccines market, 2015 - 2026 (USD Million)

  • Figure Booster Vaccines Tuberculosis Vaccines market, 2015 - 2026 (USD Million)

  • Figure Others Tuberculosis Vaccines market, 2015 - 2026 (USD Million)

  • Figure Hospitals market, 2015 - 2026 (USD Million)

  • Figure Clinics market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Tuberculosis Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table North America Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table North America Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table North America Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Canada Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Canada Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Europe Tuberculosis Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Europe Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Europe Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Europe Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Germany Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Germany Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table France Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table France Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Italy Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Italy Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Spain Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Spain Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Tuberculosis Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table China Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table China Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Japan Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Japan Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table India Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table India Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Tuberculosis Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table MEA Tuberculosis Vaccines market, by country, 2015 - 2026 (USD Million)

  • Table MEA Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table MEA Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table MEA Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Tuberculosis Vaccines market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Tuberculosis Vaccines market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Tuberculosis Vaccines market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table IDT Biologics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Taj Pharmaceuticals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GlaxoSmithKline Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table GreenSignal Bio Pharma Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sanofi Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Serum Institute of India Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table China National Biotec Group Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bavarian Nordic Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Japan BCG Lab Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Merck Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top